2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

• 2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid
• N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl]-L-glycyl]-L-glutamic acid
• Nikkomycin I
• Brn 5212470
• L-Glutamic acid, N-(L-2-(5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl)-((3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyrimidinyl)-L-valyl)glycyl)-, (2R-(2-alpha,3-beta,4-beta,5-alpha))-
• L-Glutamic acid, (3S,4S)-4-(5-hydroxy-2-pyridinyl)-3-methyl-L-homoseryl-(6R)-2-amino-3,6-anhydro-2-deoxy-6-C-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)-L-allonoyl-
• 77368-60-6
• C25H32N6O13